Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinomaChristelle Bouchart, Jean‐Luc Van Laethem, Alain Hendlisz et al.|Therapeutic Advances in Medical Oncology|2021Cited by 29
Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center EvaluationMartin Manderlier, Christelle Bouchart, Julie Navez et al.|Cancers|2022Cited by 22
PD-0420: Induction by mFOLFIRINOX followed by SIBSBRT for the neoadjuvant treatment of pancreatic cancer.Christelle Bouchart, Jean‐Luc Van Laethem, Jean-Luc Engelholm et al.|Radiotherapy and Oncology|2020Cited by 0
PO-1378 Isotoxic high-dose SBRT versus CRT for localized pancreatic cancer : a single center evaluationMartin Manderlier, Christelle Bouchart, Julie Navez et al.|Radiotherapy and Oncology|2023Cited by 0